4.7 Article

The short isoform of MS4A7 is a novel player in glioblastoma microenvironment, M2 macrophage polarization, and tumor progression

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers

Yangjun Zhang et al.

Summary: This study presents an updated version of the OncoSplicing database, which integrates a large number of alternative splicing events across various cancers to provide clinically relevant information on alternative splicing.

NUCLEIC ACIDS RESEARCH (2022)

Article Cell Biology

Overexpression of Dermokine-? enhances the proliferation and epithelial-mesenchymal transition of pancreatic tumor cells

Yan Zhang et al.

Summary: This study found that DMKN-alpha gene is overexpressed in cancerous pancreatic cells and its overexpression enhances the proliferation, migration, invasion, and EMT of pancreatic cancer cells.

CELLULAR SIGNALLING (2022)

Article Oncology

Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias

Eleonora Makela et al.

Summary: A novel variant of the oncoprotein CIP2A, named NOCIVA, was discovered and found to be clinically relevant in predicting tyrosine kinase inhibitor therapy resistance in myeloid leukemias.

CLINICAL CANCER RESEARCH (2021)

Article Biotechnology & Applied Microbiology

Imbalance of TGF-β1/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness

Junya Ning et al.

Summary: The imbalance of TGF-β1/BMP-7 pathways is associated with aggressive features and poor outcomes in HCC. Modulating this imbalance through miR-17-92 cluster and ACVR1 inhibitors could be a potential therapeutic strategy for HCC.

MOLECULAR THERAPY (2021)

Article Multidisciplinary Sciences

Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages

Natalia Ochocka et al.

Summary: The study reveals molecular heterogeneity among myeloid cells in naive and glioma-bearing brains in mice, as well as a gender-specific gene expression in glioma-activated microglia, which is also supported by bulk and scRNA-seq data from human diffuse gliomas.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

MyD88 in myofibroblasts enhances colitis-associated tumorigenesis via promoting macrophage M2 polarization

Qi Yuan et al.

Summary: The signal adaptor MyD88 plays a crucial role in colorectal cancer development, particularly in myofibroblasts. MyD88-deficient mice show resistance to drug-induced tumorigenesis, indicating the importance of MyD88 signaling in cancer development.

CELL REPORTS (2021)

Article Biochemistry & Molecular Biology

Integrated analysis of multimodal single-cell data

Yuhan Hao et al.

Summary: The study introduces a weighted-nearest neighbor analysis framework to learn the relative utility of each data type in each cell, enabling integrative analysis of multiple modalities. Applied to a CITE-seq dataset, the method constructs a multimodal reference atlas of the circulating immune system and successfully identifies and validates previously unreported lymphoid subpopulations.
Review Neurosciences

Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma

Hao Wu et al.

Summary: Glioma is a highly malignant tumor with limited treatment options, highlighting the importance of seeking effective therapeutic strategies. Research on glioblastoma mainly focuses on immunotherapy and targeted therapy, with CD47/CD24 antibody treatment being a key area of study.

CNS NEUROSCIENCE & THERAPEUTICS (2021)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Article Oncology

Spliceosome-regulated RSRP1-dependent NF-κB activation promotes the glioblastoma mesenchymal phenotype

Yaomin Li et al.

Summary: The study identified that RSRP1 promotes the MES phenotype in GBM by facilitating GBM cell invasion and apoptosis resistance through mediating spliceosome assembly. RSRP1-regulated AS event results in the formation of an oncogenic isoform that is unable to effectively suppress NF-kappa B. Targeting AS via RSRP1-related spliceosomal factors might offer a promising treatment for GBM.

NEURO-ONCOLOGY (2021)

Editorial Material Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications

Patrick Y. Wen et al.

NEURO-ONCOLOGY (2021)

Review Pharmacology & Pharmacy

Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance

Wei Wu et al.

Summary: Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor with highly infiltrative nature and treatment resistance, highlighting the importance of innovative treatment strategies. The standard treatment for GBM is surgical resection followed by chemoradiotherapy, but the robust DNA repair and self-renewing capabilities of GBM cells lead to resistance against current therapies.

PHARMACOLOGICAL RESEARCH (2021)

Review Immunology

Feature Review The tetraspan MS4A family in homeostasis, immunity, and disease

Irene Mattiola et al.

Summary: The MS4A family members have differential and selective expression in immunocompetent cells and modulate the signaling activity of various immunoreceptors. Studies suggest that they play key roles in different pathological settings such as cancer, infectious diseases, and neurodegeneration. Therefore, MS4A family members could be potential candidate biomarkers and therapeutic targets for various conditions.

TRENDS IN IMMUNOLOGY (2021)

Article Oncology

In Vitro and In Vivo Enhancement of Temozolomide Effect in Human Glioblastoma by Non-Invasive Application of Cold Atmospheric Plasma

Vikas Soni et al.

Summary: The combination therapy of cold atmospheric plasma (CAP) and Temozolomide (TMZ) shows promising results in inhibiting Glioblastoma (GBM) growth, enhancing the effectiveness of TMZ, and sensitizing GBM to treatment. Further analysis indicates an impact on cell cycle pathways and suggests the potential use of non-invasive translational therapies for GBM treatment.

CANCERS (2021)

Article Cell Biology

Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF-β upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury

Masahito Nakazaki et al.

Summary: Intravenous infusion of bone marrow-derived mesenchymal stem/stromal cells (MSCs) leads to the release of small extracellular vesicles (sEVs) that can target the injury site in spinal cord injury (SCI) rats and interact with M2 macrophages. Fractionated dosing of MSC-sEVs over 3 days is required to achieve therapeutic effects, mimicking the results of single MSC infusion. These findings suggest that the release of sEVs by MSCs over time induces a cascade of cellular responses leading to improved functional recovery.

JOURNAL OF EXTRACELLULAR VESICLES (2021)

Article Multidisciplinary Sciences

Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity

Christina A. von Roemeling et al.

NATURE COMMUNICATIONS (2020)

Review Oncology

Biomarkers for immunotherapy for treatment of glioblastoma

John P. Lynes et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Review Immunology

Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Oncology

Immunotherapy in CNS cancers: the role of immune cell trafficking

Nivedita M. Ratnam et al.

NEURO-ONCOLOGY (2019)

Review Oncology

Brain Tumor Microenvironment and Host State: Implications for Immunotherapy

William Tomaszewski et al.

CLINICAL CANCER RESEARCH (2019)

Article Biochemistry & Molecular Biology

GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2019)

Review Immunology

Mechanisms of immunotherapy resistance: lessons from glioblastoma

Christopher M. Jackson et al.

NATURE IMMUNOLOGY (2019)

Article Genetics & Heredity

Classification of glioma based on prognostic alternative splicing

Yaomin Li et al.

BMC MEDICAL GENOMICS (2019)

Review Biochemistry & Molecular Biology

Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution

Jernej Ule et al.

MOLECULAR CELL (2019)

Article Multidisciplinary Sciences

Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma

Gregor Hutter et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Multidisciplinary Sciences

VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages

Xiaoyong Huang et al.

SCIENCE ADVANCES (2019)

Review Oncology

Molecular markers in glioma

Kirsten Ludwig et al.

JOURNAL OF NEURO-ONCOLOGY (2017)

Review Cell Biology

Alternative splicing as a regulator of development and tissue identity

Francisco E. Baralle et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)

Article Cell Biology

The Functional Impact of Alternative Splicing in Cancer

Hector Climente-Gonzalez et al.

CELL REPORTS (2017)

Article Oncology

The Microenvironmental Landscape of Brain Tumors

Daniela F. Quail et al.

CANCER CELL (2017)

Review Cell Biology

The MS4A family: counting past 1, 2 and 3

Li Eon Kuek et al.

IMMUNOLOGY AND CELL BIOLOGY (2016)

Review Pharmacology & Pharmacy

Overcoming the blood-brain tumor barrier for effective glioblastoma treatment

O. van Tellingen et al.

DRUG RESISTANCE UPDATES (2015)

Article Biochemical Research Methods

The Phyre2 web portal for protein modeling, prediction and analysis

Lawrence A. Kelley et al.

NATURE PROTOCOLS (2015)

Review Pharmacology & Pharmacy

Glioblastoma multiforme: Pathogenesis and treatment

Constantinos Alifieris et al.

PHARMACOLOGY & THERAPEUTICS (2015)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Biochemistry & Molecular Biology

The Somatic Genomic Landscape of Glioblastoma

Cameron W. Brennan et al.

Review Immunology

Immune Therapy for Cancer

Michael Dougan et al.

ANNUAL REVIEW OF IMMUNOLOGY (2009)

Article Genetics & Heredity

CFFM4:: a new member of the CD20/Fcε-RIβ family

MC Gingras et al.

IMMUNOGENETICS (2001)

Article Biochemistry & Molecular Biology

KEGG: Kyoto Encyclopedia of Genes and Genomes

M Kanehisa et al.

NUCLEIC ACIDS RESEARCH (2000)